At the time of writing, SELLAS Life Sciences Group Inc [SLS] stock is trading at $1.74, saw in change for the day. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SLS shares have gain 7.41% over the last week, with a monthly amount glided 3.57%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
SELLAS Life Sciences Group Inc [NASDAQ: SLS] stock has seen the most recent analyst activity on July 21, 2021, when Cantor Fitzgerald initiated its Overweight rating and assigned the stock a price target of $18. On April 02, 2018, H.C. Wainwright initiated with a Buy rating and assigned a price target of $11 on the stock. Maxim Group upgraded its rating to a Buy but stick to its price target of $13 on March 19, 2018.
For the past year, the stock price of SELLAS Life Sciences Group Inc fluctuated between $0.77 and $2.48. Currently, Wall Street analysts expect the stock to reach $2.8 within the next 12 months. SELLAS Life Sciences Group Inc [NASDAQ: SLS] shares were valued at $1.74 at the most recent close of the market. An investor can expect a potential return of 60.92% based on the average SLS price forecast.
Analyzing the SLS fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.81, Equity is -1.33 and Total Capital is -1.03. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.03.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.6867 points at the first support level, and at 1.6333 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.7967, and for the 2nd resistance point, it is at 1.8533.
Ratios To Look Out For
It is important to note that SELLAS Life Sciences Group Inc [NASDAQ:SLS] has a current ratio of 8.28. In addition, the Quick Ratio stands at 8.28 and the Cash Ratio stands at 4.23.
Transactions by insiders
Recent insider trading involved Kalin Katherine Bach, Director, that happened on Nov 19 ’25 when 63400.0 shares were purchased. Director, VAN NOSTRAND ROBERT L completed a deal on Jun 12 ’25 to buy 10000.0 shares. Meanwhile, Director Wasman Jane bought 20000.0 shares on May 30 ’25.
